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Sion, Switzerland
‡Chemistry Department, Fudan University, 220 Handan Road, 200433 Shanghai, China
*S Supporting Information
ABSTRACT: A highly sensitive method based on mass-barcoded gold nanoparticles (AuNPs) and immunomagnetic separation
has been developed for multiplex allergy diagnosis by MALDI mass spectrometry in a component-resolved manner. Diﬀerent
analytical probes were prepared by coating AuNPs with individual allergenic proteins and mass barcode, represented by
polyethylene glycol molecules of various chain lengths. Magnetic beads (MBs) functionalized with antihuman IgE antibodies
(Abs) were used as immunomagnetic capture probes. IgE Abs were extracted from a patient’s blood serum by the formation of a
sandwich structure between the AuNPs and MBs. Multiple speciﬁc IgE Abs were simultaneously identiﬁed by mass spectrometry
detection of the mass barcodes, providing an eﬃcient component-resolved allergy diagnosis. Because of the signal ampliﬁcation
provided by the mass barcodes, the developed diagnosis method is very sensitive, with a limit of detection down to picograms per
milliliter level for speciﬁc IgE Abs. The method can be potentially useful when the sample amount is highly limited and a
multiplex diagnostic procedure is required.
Mass barcode-based mass spectrometry (MS) signalampliﬁcation is a technique widely utilized in DNA
assays,1,2 immunoassays,3,4 and tissue imaging.5,6 Mass
barcodes, which are small tag molecules and easily detectable
by MS, are grafted on nano/micro-particles in large excess
together with the large target biomolecules. The detection of
these tag molecules results in an ampliﬁed signal of the targets.
For immunoassays,3,4,7 the mass barcodes have been utilized to
probe the IgG antibodies (Abs)-involved immune binding
events on a biochip or a gold plate, which acted as a ﬂat surface
to capture and separate the antigens from bulk solutions. This
surface-based separation approach requires a multiple-step
procedure, which is rather cumbersome and time-consuming.
Besides, the full accessibility of antigens to the Abs, which are
preimmobilized on a 2D surface, is also limited.
Meanwhile, commercially available micromagnetic beads
(MBs) with immunoaﬃnity coating are more advantageous
for fast and convenient isolation of the target molecules. They
possess large active surface area and are easy in manipulation.
The immunoreactions can be performed in a homogeneous
way through gentle mixing of MBs with other reagents and may
result in a faster target-binding process. Optimization of the
target enrichment for sensitive analysis can also be easily
realized by adjusting the MBs amount and the ﬁnal sample
volume applied for analysis. Therefore, the combination of
MBs-based immunoassays with mass barcode signal ampliﬁca-
tion protocol can be promising for MS detection of large
biomolecules such as allergens.
Allergies, especially the ones caused by food products and
plant pollen, are a constantly growing health problem
worldwide.8 As pollen and foodstuﬀ often contain multiple
allergenic proteins that can provoke allergic reactions for a
patient, component resolved diagnosis (CRD) should be
performed.8 Allergy CRD is typically performed with individual
puriﬁed allergenic proteins to detect the level of speciﬁc IgE
Abs in human blood serum by enzyme-linked immunosorbent
assay (ELISA).9 Commercially available ELISA-based kits10 or
automated platforms for allergy CRD usually require 20−50 μL
of blood serum and provide the limit of detection (LOD) for
speciﬁc IgE Abs as low as 0.24 ng/mL (0.1 IU/mL) level.11
Fluorophore-labeled immunoassay,12 magnetophoretic immu-
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noassay,13 interferometric reﬂectance imaging sensors,14 and
immunoaﬃnity capillary electrophoresis (IACE) coupled with
MS detection,15 were also developed. However, in the listed
analytical methods, the allergy diagnosis usually relies on
expensive enzyme or ﬂuorescent labels. Special devices, such as
the antigen array immobilized on a 2D surface, the microﬂuidic
chip, or the separation capillary preloaded with aﬃnity probes,
are also required for these techniques, making them quite
complex and laborious. Regarding these factors above, the
simpliﬁcation of the device, improvement of sensitivity and
reduction of sample consumption are still needed and under
development for the analysis of speciﬁc IgE Abs in the allergic
patient’s blood serum.
Here, we employ a mass barcode ampliﬁcation strategy
combined with commercial protein A/G coated-MBs (protein
A/G@MBs) to enhance the simplicity and sensitivity of the
multiplex allergy CRD with MS detection as displayed in Figure
1. Polyethylene glycol molecules with diﬀerent chain lengths
were chosen as mass barcodes and grafted onto gold
nanoparticles (AuNPs) that were further modiﬁed with speciﬁc
allergenic proteins to form AuNPs probes. At the same time,
protein A/G@MBs were modiﬁed with antihuman IgE Abs and
formed a sandwich structure with speciﬁc IgE Abs from
patient’s blood serum and AuNPs probes. The MS detection of
the mass barcodes from AuNPs indicated the presence of
respective speciﬁc IgE Abs and allowed allergy CRD in a highly
sensitive manner. LOD of 18 pg/mL (7.5 mIU/mL) for speciﬁc
IgE Abs was achieved for the analysis of antibeta-lactoglobulin
Abs in model experiments, allowing using afterward only 1 μL
of blood serum from allergic patient for CRD diagnosis.
■ EXPERIMENTAL SECTION
Allergy CRD with the Patient’s Blood Serum. First, the
citrate-stabilized AuNPs were derivatized with the mixed thiol-
containing oligomers of mass barcodes and protein linkers.
Various allergenic proteins-conjugated AuNPs probes were
then produced by immobilizing individual puriﬁed cow’s milk
proteins, including lactoferrin, bovine serum albumin (BSA), β-
lactoglobulin B (β-lac B), α-casein, β-casein, and κ-casein, onto
the AuNPs with distinct mass barcodes covalently. More details
about the used reagents, synthesis procedure of AuNPs and
mass-barcoded AuNPs probes, and their relevant character-
izations are given in Supporting Information, SI-1, SI-2, and SI-
3.
The antihuman IgE Abs-modiﬁed MBs were prepared by
incubating 10 μL of 10 mg/mL protein A/G@MBs with 5 μL
of 1 mg/mL antihuman IgE Abs for 30 min at room
temperature (RT). Blood serum of a milk allergic patient was
always diluted with 10 mM phosphate buﬀer (PB, pH 7.4) prior
to the diagnosis. Initial required volume of the serum varied
from 50 to 1 μL, depending on the dilution factor, changing
from 10 up to 100000 times. The modiﬁed MBs were then
added to 300 μL of the diluted blood serum to extract human
IgE Abs through 30 min of incubation at RT. The supernatant
was discarded and the protein A/G-antihuman IgE Abs-human
IgE Abs immunocomplex formed on MBs was resuspended
into 10 μL of 10 mM PB, pH 7.4, for subsequent use.
Allergy diagnosis was ﬁrst performed with each type of the
allergen-conjugated AuNPs separately. A total of 20 μL of
appropriate protein-conjugated AuNPs (15 nM AuNPs) were
mixed with 10 μL of the prepared human IgE-based
immunocomplex on MBs. The mixture was diluted to 300 μL
with 10 mM PB and incubated for 30 min at RT. After
magnetic separation step, acidic elution and MALDI-MS
detection of captured allergen-coated AuNPs were carried out
as described in SI-4. Multiplex allergy diagnosis was realized by
adding simultaneously various AuNPs probes (20 μL and 15
nM, each) into 10 μL of the human IgE-captured MBs. The
mixture was diluted to 300 μL with 10 mM PB and incubated
for 30 min at RT, followed by magnetic separation step, AuNPs
elution, and MALDI-MS detection.
■ RESULTS AND DISCUSSION
Combining MALDI-MS Signal Ampliﬁcation by Mass
Barcoded AuNPs with Immunomagnetic Separation:
Optimization and Validation. To obtain the best signal
ampliﬁcation, several parameters of the proposed AuNPs/
immunomagnetic separation based approach have been
optimized, including the choice of immunomagnetic support
and protein linker, as described in SI-5 and SI-6. Analysis of
antibovine β-lac B IgG Abs was chosen as a model system for
the protocol optimization. Antibovine β-lac B Abs could bind
with both protein A/G@MBs and β-lac B-coated AuNPs (β-lac
B @AuNPs) probe forming a sandwich structure and then be
detected through MALDI-MS analysis of corresponding mass
barcode, as shown in Figure S4 of SI-4. The validity and
sensitivity of the method were also evaluated based on this
model.
Figure 1. Schematic representation of coupling mass-barcoded AuNPs probes with immunomagnetic separation for simultaneous diagnosis of
multiple allergic reactions via detection of speciﬁc IgE Abs. MALDI-MS: matrix−assisted laser desorption/ionization mass spectrometry; MBs:
magnetic beads; Mbc: mass barcode.
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First of all, the amount ratio between mass barcode and
protein linker for AuNPs surface modiﬁcation needed the
optimization. Excessive mass barcode amount in comparison to
the protein linker could negatively aﬀect the protein
conjugation eﬃciency. In contrast, insuﬃcient amount of
mass barcode would lead to limited signal ampliﬁcation eﬀect.
To ﬁnd an optimal mass barcode/protein linker ratio, several
identical solutions containing 1 nM of antibovine β-lac B IgG
Abs in 300 μL of 10 mM PB were analyzed separately with the
ﬁxed amount of protein A/G@MBs (100 μg) and 20 μL of β-
lac B@AuNPs prepared with various mass barcode-to-protein
linker amount ratios (n/m) ranging from 95:5 to 75:25. The
amount of MBs was much more excessive in comparison to the
amount of IgG Abs. According to the protocol,16 provided by
the manufacturer of protein A/G@MBs, the chosen amount
was enough to ﬁx 4 μg of IgG Abs. Therefore, most of the
antibovine β-lac B IgG Abs should be immobilized on the MBs.
The amount of β-lac B@AuNPs was chosen to match the
amount of IgG Abs. For semiquantitative comparison, internal
standard-coated AuNPs (IS@AuNPs) and 2,5-dihydroxyben-
zoic acid (DHB) were deposited together with the concen-
trated sample on a MALDI target plate for MS detection, as
discussed in SI-4 and SI-7. Mass barcode 2 (Mbc2) was used as
the IS, which has similar molecular structure as the signal
reporter, Mbc1, coated on AuNPs to ensure similar ionization
eﬃciency during MALDI-MS analysis. The relative intensity of
the mass barcode to IS was considered for the evaluation of the
signal ampliﬁcation eﬀect during the detection of antibovine β-
lac B Abs. From the recorded MALDI mass spectra, Mbc1
relative intensity reached the highest value, when the mass
barcode-to-protein linker ratio was 85:15 (Figure S6(a) and (b)
in SI-8). Therefore, the oligomer mixture composed of 85%
mass barcode and 15% protein linker was selected to
functionalize AuNPs for all the following immunoassays.
With the proposed strategy, the semiquantiﬁcation of
antibovine β-lac B IgG Abs was further performed, as described
in SI-4. The method sensitivity was accessed by determining
the LOD of antibovine β-lac B IgG Abs. Following the
optimized conditions, both the amounts of the β-lac B@AuNPs
probes and protein A/G@MBs were kept constant at 300 fmol
and 100 μg respectively, while the concentration of target Abs
were decreased from 1 pM to 30 fM. Figure 2 shows the
obtained mass spectra of Mbc1 and IS with intensities
normalized to the intensity of IS. As expected, the relative
intensity of Mbc1 gradually decreased, as the concentration of
Abs decreased. Due to the signal ampliﬁcation eﬀect, the lowest
concentration of antibovine β-lac B IgG Abs that can be
analyzed with a good reproducibility was around 100 fM (18
pg/mL). Once the concentration was lowered to 70 fM, the
signal of Mbc1 was hardly detected with S/N around or less
than 3 (data not shown).
In the negative control experiment using κ-casein@AuNPs
and antibovine β-lac B Abs, only IS signal was observed in
Figure 2e. Thanks to the oligomer coating of AuNPs and
washing step applied, the obtained spectrum demonstrated
clearly the high speciﬁcity of the system. Successful suppression
of nonspeciﬁc interactions by the ethylene glycol oligomers17
was also conﬁrmed by the optical estimation of the color
diﬀerence and UV−vis absorption measurement of the
supernatant eluted from the MBs by acidic solution when
analyzing antibovine β-lac B Abs at high concentration (1 nM)
or blank sample with β-lac B@AuNPs and κ-casein@AuNPs, as
shown in Figure S7(a) and (c) in SI-9.
Multiplex Allergy CRD. The mass barcode-based MALDI-
MS signal ampliﬁcation strategy was further applied to cow’s
milk allergy CRD. In this case, the immunoaﬃnity reactions
between speciﬁc IgE Abs from the patient’s blood serum and
allergenic proteins were detected via the observation of
ampliﬁed mass barcodes signals. Antihuman IgE Abs were
immobilized onto protein A/G@MBs to selectively extract
human IgE Abs from the blood serum of the patient. A large
amount of magnetic immunosupport carrying antihuman IgE
Abs could be prepared at once with the commercial protocol16
and divided into equal portions for all the following diagnostic
steps, 100 μg per each analysis. This amount of antihuman IgE-
protein A/G@MBs was chosen to be largely in excess in
comparison to the total IgE Abs in patient’s blood serum. The
total IgE Abs concentration in the original blood serum of the
milk allergic patient was detected as 2150 ± 160 ng/mL (10
nM, or 900 ± 70 IU/mL, n = 3) by classical commercial
ELISA.15 Initial volume of the blood serum was diluted
continuously with 10 mM PB and, therefore varied depending
on the dilution factor: for example, 50 μL were for 10 times
dilution, 10 μL for 50 times dilution, and 1 μL for the dilution
500 times and higher. Then, 300 μL of the samples diluted
were analyzed separately to evaluate the diagnosis sensitivity as
described below.
Figure 2. Detection of antibovine β-lac B IgG Abs by mass barcoded
AuNPs-based MALDI-MS signal ampliﬁcation method combined with
immunomagnetic separation. MALDI mass spectra obtained for the
analyses of (a) 1 pM, (b) 300 fM, (c) 100 fM, and (d) 30 fM of
antibovine β-lac B Abs. (e) 1 pM of antibovine β-lac B Abs analyzed
with κ-casein conjugated AuNPs as a negative control. Conditions: Abs
in 300 μL of 10 mM PB, 100 μg of protein A/G@MBs, 300 fmol
AuNPs, 85:15 of Mbc1: protein linker ratio; Rel.: relative.
Analytical Chemistry Technical Note
DOI: 10.1021/acs.analchem.6b01142
Anal. Chem. 2016, 88, 6184−6189
6186
First, diagnosis was performed with individual AuNPs
probes, Mbc1-coded lactoferrin@AuNPs, Mbc2-coded BSA@
AuNPs or Mbc3-coded β-lac B@AuNPs using the protocol,
illustrated in Figure 1. Among the three whey proteins, BSA@
AuNPs and lactoferrin@AuNPs displayed the binding with the
patient’s IgE Abs on MBs based on the corresponding
observation of Mbc1 and Mbc2 peaks in MS spectra (Figure
3). The Mbc1 and Mbc2 signals were still detectable even when
the blood serum was diluted 100000 and 30000 times, as shown
in Figure 3b and d, respectively. Considering that the original
total concentration of the IgE Abs in the blood serum was
around 10 nM (900 IU/mL), lactoferrin- and BSA-speciﬁc IgE
Abs were still detectable with the total IgE Abs concentrations
of 100 and 300 fM (18 and 54 pg/mL or 7.5 and 22.5 mIU/
mL), respectively. Owing to such sensitivity, less than 1 μL of
original patient’s blood serum could be enough for the allergy
CRD based on MS signal ampliﬁcation.
In contrast, no signal of Mbc3 at m/z 957 was observed for
β-lac B@AuNPs even with the 10 times diluted patient’s blood
serum, (Figure 3e), indicating that the patient should not be
allergic to bovine β-lac, while he may have an allergy to BSA
and lactoferrin.
To check the feasibility of the present strategy for multiplex
analysis, the CRD of cow’s milk allergy was performed with
various AuNPs probes simultaneously in a single run. For this
purpose, same amounts of the three kinds of AuNPs probes
(300 fmol each) were mixed together to react with the patient’s
IgE Abs extracted on the MBs. As each kind of AuNPs probe
binds with its speciﬁc IgE Abs from the patient’s serum without
competition, the experimental parameters, for example, amount
of individual AuNPs probes, were kept the same as those in
individual allergen identiﬁcation. As expected, for patient’s
blood serum diluted 30000 times, both signals of Mbc1 for
lactoferrin speciﬁc IgE Abs and Mbc2 for BSA speciﬁc IgE Abs
were detected, but without Mbc3 signal for β-lac B speciﬁc IgE
Abs, as shown in Figure 4(a1). When the serum was diluted by
100000 times, the Mbc2 signal could not be observed any
more, while Mbc1 was still detectable (Figure 4(a2)), in
accordance with the results obtained using individual AuNPs
probes. These results demonstrate that the multiplex diagnosis
would not sacriﬁce detection sensitivity, but could provide a
gain in time and reagent consumption.
The same protocol was further applied for the multiplex
diagnosis of allergy to caseins. Mbc1 mass barcode was used for
α-casein@AuNPs, while Mbc2 and Mbc3 mass barcodes were
utilized for β- and κ-casein@AuNPs probes. With 50 times and
1000 times diluted patient’s serum, only Mbc1 was observed,
demonstrating that the patient is solely allergic to α-casein. In
comparison with lactoferrin and BSA, the Mbc1 signal from α-
casein conjugated AuNPs probes was observed at LOD level
with 1000 times diluted serum, as shown in Figure 4(b2).
Figure 3. Diagnosis of cow’s milk allergy with individual AuNPs
probes combined with immunomagnetic separation. MALDI mass
spectra of Mbc1 for lactoferrin allergy diagnosis with the patient’s
serum diluted (a) 30000 and (b) 100000 times. MALDI mass spectra
of Mbc2 for BSA allergy diagnosis with the patient’s blood serum
diluted (c) 10000 and (d) 30000 times. (e) Mass spectrum obtained
using the Mbc3 coded β-lac@AuNPs and 10 times diluted patient’s
serum. Conditions: diluted sample volume of 300 μL, 100 μg of
antihuman IgE-protein A/G@MBs and 300 fmol AuNPs probes.
Figure 4. (a) Multiplex diagnosis of lactoferrin allergy (Mbc1), BSA
allergy (Mbc2), and β-lac B allergy (Mb3) by AuNPs probes combined
with immunomagnetic separation. MALDI mass spectra obtained with
the patient’s blood serum diluted (1) 30000 and (2) 100000 times. (b)
Multiplex diagnosis of α-casein (Mbc1 coded), β-casein (Mbc2
coded), and κ-casein (Mbc3 coded) allergies. [(1) and (2)] MALDI
mass spectra obtained with the patient’s blood serum diluted (1) 50
and (2) 1000 times. Conditions: diluted sample volume of 300 μL, 100
μg of antihuman IgE coated MBs, and 300 fmol of each kind of AuNPs
probes.
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These data reveal that the amount of α-casein speciﬁc IgE Abs
existing in the blood serum is approximately 30 and 100 times
lower than the amount of BSA and lactoferrin speciﬁc IgE Abs,
respectively.
These results are in good accordance with those, previously
obtained by IACE-UV/MS strategy and classical ELISA
protocol,15 conﬁrming the reliability of the present procedure.
This diagnostic approach is qualitative, but provides the
possibility to make a conclusion about the relative abundance
of individual allergen speciﬁc IgE Abs coexisting in the patient’s
blood serum: speciﬁc IgE Abs to lactoferrin > IgE Abs to BSA >
IgE Abs to α-casein. Such a comparison is feasible, since the
diagnosis is only based on the observation of mass barcode
molecules, which have similar molecular structures and
comparable sensitivities during MALDI-MS analysis, as shown
in Figure S8 in SI-10.
Comparison with Existing Approaches for Allergy
Diagnosis. Diﬀerent from the previous work based on IACE-
UV/-MS, this strategy aims at sensitively detecting speciﬁc IgE
Abs in the allergic patient’s blood serum with a set of known
allergenic proteins. With the three mass-barcoded and allergen-
conjugated AuNPs, we have demonstrated the proof-of-concept
of this strategy for qualitative multiplex allergy CRD. A high
throughput multiplex diagnosis can be potentially realized by
preparing more AuNPs modiﬁed with diﬀerent mass barcode
molecules and allergenic proteins. The high resolution of MS
detection aﬀords a wide choice of PEG based mass barcodes to
perform the analysis of speciﬁc IgE Abs against various
allergens within a single assay.
The arbitrarily selected mass barcodes, easily controllable
MBs in tube and sensitive MS detection allow performing
multiplexed allergy diagnosis in a simple manner, avoiding the
use of spatially resolved architectures, such as microarray
systems,11,12 costly ﬂuorescent18 or enzyme labels,19 and
capillary electrophoresis that needs laborious preloading of
immunoaﬃnity MBs and coupling with MS detection of the
collected CE fractions for simultaneous antigen identiﬁcation
instead of UV analysis.15 Owing to the signal ampliﬁcation
procedure, the allergy diagnosis sensitivity has been enhanced
to a level, which is 13 times better than that obtained with
IACE-UV analysis15 and comparable to previously reported
results employing nanocrystal clusters20 or nanoparticle hybrid
probes.21 In another case, surface plasmon resonance signals
from AuNPs have been shown to provide ultrasensitive total
IgE quantiﬁcation with LOD of only 0.18 pg/mL (0.075 mIU/
mL).22 However, the method only provided quantiﬁcation of
the standard IgE solution instead of allergy CRD using patient’s
blood serum. Due to the high sensitivity, our method requires
extremely low amount (3−30 nL in theory) of patient’s blood
serum in contrast to 20−100 μL of blood serum consumption
by commercial ELISA or other developed methods and 2 μL by
microarray chip with DLC solid support23 or IACE-UV/MS
approach.15
In addition, another three speciﬁc features distinguish this
analysis platform from previously developed Au particle-based
MS signal ampliﬁcation for immunoassay performed on gold
chips.3,4 First, MBs as the immunosupport with large surface
area are commercially available with a wide variety of surface
functionalization. They provide great ﬂexibility for immuno-
assay design in eﬀective and simple manner without complex
and time-consuming surface conjugation processes for the gold
chip. Second, the immune reactions may be faster in bulk
solution with stirring in comparison with one on a ﬁxed gold
surface, facilitating sample handling and accelerating the
immunobinding process. Third, deposition of concentrated
AuNPs together with IS on the MALDI plate can provide more
homogeneous MS analysis and allow avoiding spot-to-spot
variation during the direct detection on the gold chip or
complicated concentration process of AuNPs by centrifugation
after their detachment from the gold chip.
All in all, due to the simplicity, tiny sample consumption and
high sensitivity, the present technique can be a helpful tool for
ultratrace analysis during clinical allergy diagnosis.
■ CONCLUSIONS
In this study, we have constructed a MALDI-MS signal
ampliﬁcation system based on mass-barcoded AuNPs and
immunomagnetic separation. We have applied this system to
enhance the sensitivity of allergy CRD. For diagnostic purpose,
the patient’s IgE Abs were ﬁrst extracted from the blood serum
by antihuman IgE Abs modiﬁed MBs, and then probed by
diﬀerent mass-barcoded and allergenic proteins-conjugated
AuNPs. The immunobinding events between the patient’s
IgE Abs and allergens were reported by the corresponding mass
barcodes. High sensitivity and potential for multiplexing allergy
CRD were successfully demonstrated with down to 1 μL of the
initial patient’s blood serum, that could be diluted up to 100000
times prior to the analysis. Besides the food allergen diagnosis,
we believe that this system can be easily modiﬁed and applied
to many other immunoassays with a vast range of target
analytes.
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